This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignees: Il-Yang Pharm. Co., Ltd, Industry-Academic Cooperation Foundation, Sookmyung Women's University, Samsung Life Public Welfare Foundation. Active years: 2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:

Years Active: 2016
Title: Hae Kyoung Lim: Innovator in Anti-Inflammatory Peptides
Introduction
Hae Kyoung Lim is a notable inventor based in Yongin-si, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the development of peptides with anti-inflammatory properties. His innovative work has the potential to impact various health-related applications.
Latest Patents
Hae Kyoung Lim holds a patent for "Peptides and use thereof." This invention focuses on novel peptides that exhibit anti-inflammatory effects. The patent encompasses a polynucleotide encoding the peptide, a pharmaceutical composition for preventing or treating inflammatory diseases, and various drug compositions aimed at alleviating inflammation. Additionally, it includes methods for treating inflammatory diseases and designing peptide mimetics.
Career Highlights
Throughout his career, Hae Kyoung Lim has worked with prominent organizations, including the Samsung Life Public Welfare Foundation and Il-yang Pharm. Co., Ltd. His experience in these companies has allowed him to collaborate with other professionals in the field and contribute to significant advancements in pharmaceutical research.
Collaborations
Hae Kyoung Lim has collaborated with notable colleagues such as Dae Ho Cho and Min Kyung Jung. These partnerships have facilitated the exchange of ideas and expertise, further enhancing the impact of his work in the industry.
Conclusion
Hae Kyoung Lim's contributions to the field of anti-inflammatory peptides demonstrate his commitment to innovation and improving health outcomes. His patent and collaborations highlight the importance of research in developing effective treatments for inflammatory diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile